These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19020634

  • 1. Use of fluorescein and indocyanine green angiography in polypoidal choroidal vasculopathy patients following photodynamic therapy.
    Windisch R, Windisch BK, Cruess AF.
    Can J Ophthalmol; 2008 Dec; 43(6):678-82. PubMed ID: 19020634
    [Abstract] [Full Text] [Related]

  • 2. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [Abstract] [Full Text] [Related]

  • 3. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [Abstract] [Full Text] [Related]

  • 4. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M, Barbazetto IA, Freund KB.
    Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115
    [Abstract] [Full Text] [Related]

  • 5. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration.
    Chung SE, Kang SW, Lee JH, Kim YT.
    Ophthalmology; 2011 May; 118(5):840-5. PubMed ID: 21211846
    [Abstract] [Full Text] [Related]

  • 6. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN, Gandhi JS, Nair-Sahni J, Heimann H, Pournaras CJ, Harding SP.
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [Abstract] [Full Text] [Related]

  • 7. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.
    Honda S, Imai H, Yamashiro K, Kurimoto Y, Kanamori-Matsui N, Kagotani Y, Tamura Y, Yamamoto H, Ohoto S, Takagi H, Uenishi M, Negi A.
    Ophthalmologica; 2009 Nov; 223(5):333-8. PubMed ID: 19478533
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A, Shiraga F, Shiragami C, Ono A, Tenkumo K.
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Song MH, Ryu HW, Roh YJ.
    Ophthalmologica; 2011 Mar; 226(3):119-26. PubMed ID: 21757883
    [Abstract] [Full Text] [Related]

  • 14. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
    Kang HM, Koh HJ, Lee CS, Lee SC.
    Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F, Sawa M, Wakabayashi T, Sasamoto Y, Suzuki M, Tsujikawa M.
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.
    Saito M, Iida T, Nagayama D.
    Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY, Lee GK, Luk FO, Lam DS.
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.